TrialBMC infectious diseases2024

Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial.

Ananda Wijewickrema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.